Sentry Investment Management LLC Trims Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sentry Investment Management LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 23.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,866 shares of the medical equipment provider's stock after selling 557 shares during the period. Intuitive Surgical comprises 0.5% of Sentry Investment Management LLC's investment portfolio, making the stock its 28th largest position. Sentry Investment Management LLC's holdings in Intuitive Surgical were worth $865,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Global Financial Private Client LLC boosted its position in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares in the last quarter. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 25,443 shares of company stock valued at $12,692,195 over the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $0.98 during midday trading on Friday, reaching $557.08. 1,103,774 shares of the company's stock traded hands, compared to its average volume of 1,641,815. The company has a market cap of $199.67 billion, a price-to-earnings ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a one year low of $413.52 and a one year high of $616.00. The stock has a 50 day moving average of $521.99 and a 200 day moving average of $539.26.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the company posted $1.50 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

ISRG has been the topic of several research reports. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Citigroup restated a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Robert W. Baird dropped their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Finally, Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.